Search Results

AZD3759 50mg 50mg  | Purity Not Available

Adooq Bioscience

AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR). It binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR.

More Information Supplier Page

AZD3759 25mg 25mg  | Purity Not Available

Adooq Bioscience

AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR). It binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR.

More Information Supplier Page

AZD3759 10mg 10mg  | Purity Not Available

Adooq Bioscience

AZD3759 is an orally available inhibitor of the epidermal growth factor receptor (EGFR). It binds to and inhibits the activity of EGFR as well as certain mutant forms of EGFR.

More Information Supplier Page

CCT244747 5mg 5mg  | Purity Not Available

Adooq Bioscience

CCT244747 is a novel potent, highly selective, orally active ATP-competitive CHK1 inhibitor with potential anticancer activity,

More Information Supplier Page

CCT244747 2mg 2mg  | Purity Not Available

Adooq Bioscience

CCT244747 is a novel potent, highly selective, orally active ATP-competitive CHK1 inhibitor with potential anticancer activity,

More Information Supplier Page

CCT244747 10mg 10mg  | Purity Not Available

Adooq Bioscience

CCT244747 is a novel potent, highly selective, orally active ATP-competitive CHK1 inhibitor with potential anticancer activity,

More Information Supplier Page